Max Delbrück Center for Molecular Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2023

  1. Ravulizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

    Annals of Neurology, Vol. 93, Núm. 6, pp. 1053-1068